What is the best pharmacological treatment for major depression in a female adult with autism and unmedicated ADHD? The patient experienced increased anxiety after starting citalopram 10mg, and this persisted for 4 weeks.
Fuente:
Zenodo
Salvato in:
| Autore principale: | |
|---|---|
| Natura: | Recurso digital |
| Pubblicazione: |
Zenodo
2025
|
| Soggetti: | |
| Accesso online: | |
| Tags: |
Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne!!
|
| _version_ | 1866901251038380032 |
|---|---|
| author | Tripdatabase |
| author_facet | Tripdatabase |
| contents | Duloxetine, mirtazapine, bupropion, vortioxetine, and agomelatine are potential options for managing depression in adults with ASD and ADHD, given the reported adverse effects of SSRIs like citalopram. |
| format | Recurso digital |
| id | zenodo_https___doi_org_10_5281_zenodo_18509575 |
| institution | Zenodo |
| language | |
| publishDate | 2025 |
| publisher | Zenodo |
| record_format | zenodo |
| spellingShingle | What is the best pharmacological treatment for major depression in a female adult with autism and unmedicated ADHD? The patient experienced increased anxiety after starting citalopram 10mg, and this persisted for 4 weeks. Tripdatabase best pharmacological treatment major depression female adult autism unmedicated adhd patient experienced increased anxiety after starting citalopram 10mg persisted weeks Duloxetine, mirtazapine, bupropion, vortioxetine, and agomelatine are potential options for managing depression in adults with ASD and ADHD, given the reported adverse effects of SSRIs like citalopram. |
| title | What is the best pharmacological treatment for major depression in a female adult with autism and unmedicated ADHD? The patient experienced increased anxiety after starting citalopram 10mg, and this persisted for 4 weeks. |
| topic | best pharmacological treatment major depression female adult autism unmedicated adhd patient experienced increased anxiety after starting citalopram 10mg persisted weeks |
| url | https://doi.org/10.5281/zenodo.18509575 |